Dsmb

Rediff.com » News » Dsmb

News for Dsmb

News

Covaxin gets nod for phase 2, 3 clinical trials on 2-18 year-olds

Bharat Biotech's COVID-19 vaccine Covaxin was on Tuesday recommended by an expert panel for phase II/III clinical trial on those aged between two to 18 years, official sources said. IMAGE: Kindly......

Oxford jabs effective against severe Covid: US trial

A large trial in the United States and two South American countries of the Oxford-AstraZeneca vaccine has shown 79 per cent efficacy rate at preventing symptomatic COVID-19 and 100 per cent......

Serum Institute ready to roll out Covid vaccine

With the government approving two COVID-19 vaccines for emergency use, Serum Institute on Sunday said it is ready to roll out Covishield vaccine in India in the coming weeks, while Bharat Biotech......

Never spoke about vaccinating entire country: Govt

The Centre on Tuesday said there may not be a need to vaccinate the country's entire population against COVID-19 if a critical mass of people are given a shot to break the chain of virus......

Incident with volunteer no way induced by vaccine: Serum Institute

Stressing that the Covishield vaccine is "safe and immunogenic", the Serum Institute of India on Tuesday said the incident with the Chennai volunteer was in no way induced by the vaccine as......

Rediff News

Dsmb

News for Dsmb

Covaxin gets nod for phase 2, 3 clinical trials on 2-18 year-olds

Oxford jabs effective against severe Covid: US trial

Serum Institute ready to roll out Covid vaccine

Never spoke about vaccinating entire country: Govt

Incident with volunteer no way induced by vaccine: Serum Institute

Top Coverage News

World Test Championship 2023

Manipur's Tragedy

IPL 2023

Sri Lanka's Tour of India 2023

GUJARAT, HIMACHAL GO TO POLLS